drugset
Drugs / BCG
last change Oct 2002 re-read 2 minutes ago

BCG

Vaccine

Developed for
small cell lung carcinoma
Investigated by
EORTC Lung Cancer Cooperative Group · Eli Lilly and Company · Groupe Francais De Pneumo-Cancerologie · Independent centers (Australia, New Zealand, Europe, USA) · Memorial Sloan Kettering Cancer Center · Merck KGaA, Darmstadt, Germany
+3 more · Schweizerische Arbeitsgruppe fuer angewandte Krebsforschung (SAKK) · Spanish Lung Cancer Group · US Department of Veterans Affairs

Trials 1 · a red edge is where a trial was stopped

today NCT00037713 · Ph 3
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00037713 Sep 1998 → Oct 2002 small cell lung carcinoma Eli Lilly and Company Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BCG “5 vaccinations of BEC2 (2.5 mg) + BCG given day 1 of weeks 0,2,4,6 \& 10.” NCT00037713 ↗
Modality Vaccine “BEC2 (2.5 mg)/BCG vaccination” NCT00037713 ↗